Genetic evolution of the neuraminidase of influenza a (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution

Journal of General Virology

Volumn 93, Issue PART 9, 2012, Pages 1996-2007

  Westgeest, Kim B ^a   de Graaf, Miranda ^a,b   Fourment, Mathieu ^c   Bestebroer, Theo M ^a   van Beek, Ruud ^a   Spronken, Monique I J ^a   de Jong, Jan C ^a   Rimmelzwaan, Guus F ^a   Russell, Colin A ^b,d   Osterhaus, Albert D M E ^a   Smith, Gavin J D ^c   Smith, Derek J ^a,b,d   Fouchier, Ron A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; SIALIDASE;

ARTICLE; EVOLUTION; GENETIC ANALYSIS; INFLUENZA; INFLUENZA VIRUS A H3N2; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; VIRAL GENETICS;

EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; MUTATION RATE; NEURAMINIDASE; PHYLOGENY; RECOMBINATION, GENETIC; SELECTION, GENETIC; VIRAL PROTEINS;

EID: 84865140575     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.043059-0     Document Type: Article

References (74)

1. Air, G. M., Els, M. C., Brown, L. E., Laver, W. G. & Webster, R. G. (1985). Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Virology 145, 237-248.
2. Barr, I. G., McCauley, J., Cox, N., Daniels, R., Engelhardt, O. G., Fukuda, K., Grohmann, G., Hay, A., Kelso, A. & other authors (2010). Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 28, 1156-1167.
3. Bhatt, S., Holmes, E. C. & Pybus, O. G. (2011). The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol 28, 2443-2451.
4. Blok, J. & Air, G. M. (1982). Variation in the membrane-insertion and ''stalk'' sequences in eight subtypes of influenza type A virus neuraminidase. Biochemistry 21, 4001-4007.
5. Brett, I. C. & Johansson, B. E. (2005). Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339, 273-280.
6. Chen, R. & Holmes, E. C. (2008). The evolutionary dynamics of human influenza B virus. J Mol Evol 66, 655-663.
7. Colman, P. M., Varghese, J. N. & Laver, W. G. (1983). Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41-44.
8. Colman, P. M., Laver, W. G., Varghese, J. N., Baker, A. T., Tulloch, P. A., Air, G. M. & Webster, R. G. (1987). Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 326, 358-363.
9. Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L. & Kilbourne, E. D. (1974). Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis 129, 411-420.
10. Darriba, D., Taboada, G. L., Doallo, R. & Posada, D. (2011). ProtTest 3: fast selection of best-fit models of protein evolution. Bioinformatics 27, 1164-1165.
11. de Jong, J. C., Donker, G. A., Meijer, A., van der Hoek, W., Rimmelzwaan, G. F. & Osterhaus, A. D. M. E. (2011). Het influenzaseizoen 2010/2011 in Nederland: het nieuwe A(H1N1)-virus van 2009 blijft actief. Ned Tijdschr Med Microbiol 19, 21-27.
12. Drummond, A. J. & Rambaut, A. (2007). BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7, 214.
13. Drummond, A., Pybus, O. G. & Rambaut, A. (2003). Inference of viral evolutionary rates from molecular sequences. Adv Parasitol 54, 331-358.
14. Fiore, A. E., Uyeki, T. M., Broder, K., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K. & other authors (2010). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59 (RR-8), 1-62.
15. Fitch, W. M., Bush, R. M., Bender, C. A. & Cox, N. J. (1997). Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A 94, 7712-7718.
16. Fouchier, R. A., Munster, V., Wallensten, A., Bestebroer, T.M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B. & Osterhaus, A. D. (2005). Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79, 2814-2822.
17. Goldman, N. & Yang, Z. (1994). A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 11, 725-736.
18. Guindon, S. & Gascuel, O. (2003). A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52, 696-704.
19. Gulati, U., Hwang, C.-C., Venkatramani, L., Gulati, S., Stray, S. J., Lee, J. T., Laver, W. G., Bochkarev, A., Zlotnick, A. & Air, G. M. (2002). Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J Virol 76, 12274-12280.
20. Hall, T. A. (1999). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95-98.
21. Hanada, K., Suzuki, Y. & Gojobori, T. (2004). A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol Biol Evol 21, 1074-1080.
22. Holmes, E. C., Ghedin, E., Miller, N., Taylor, J., Bao, Y., St George, K., Grenfell, B. T., Salzberg, S. L., Fraser, C. M. & other authors (2005). Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 3, e300.
23. Huelsenbeck, J. P. & Ronquist, F. (2001). MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17, 754-755.
24. Jenkins, G. M., Rambaut, A., Pybus, O. G. & Holmes, E. C. (2002). Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol 54, 156-165.
25. Johansson, B. E., Grajower, B. & Kilbourne, E. D. (1993). Infectionpermissive immunization with influenza virus neuraminidase prevents weight loss in infected mice. Vaccine 11, 1037-1039.
26. Kaverin, N. V., Matrosovich, M. N., Gambaryan, A. S., Rudneva, I. A., Shilov, A. A., Varich, N. L., Makarova, N. V., Kropotkina, E. A. & Sinitsin, B. V. (2000). Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res 66, 123-129.
27. Kendal, A. P., Schieble, J., Cooney, M. K., Chin, J., Foy, H. M. & Noble, G. R. (1978). Co-circulation of two influenza A (H3N2) antigenic variants detected by virus surveillance in individual communities. Am J Epidemiol 108, 308-311.
28. Kilbourne, E. D. (1976). Comparative efficacy of neuraminidasespecific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. J Infect Dis 134, 384-394.
29. Kilbourne, E. D., Johansson, B. E. & Grajower, B. (1990). Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proc Natl Acad Sci U S A 87, 786-790.
30. Kosakovsky Pond, S. L., Frost, S. D. & Muse, S. V. (2005). HyPhy: hypothesis testing using phylogenies. Bioinformatics 21, 676-679.
31. Kosakovsky Pond, S. L., Frost, S. D., Grossman, Z., Gravenor, M. B., Richman, D. D. & Brown, A. J. (2006). Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol 2, e62.
32. Kosakovsky Pond, S. L., Poon, A. F., Leigh Brown, A. J. & Frost, S. D. (2008). A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol 25, 1809-1824.
33. Kosakovsky Pond, S. L., Murrell, B., Fourment, M., Frost, S. D., Delport, W. & Scheffler, K. (2011). A random effects branch-site model for detecting episodic diversifying selection. Mol Biol Evol 28, 3033-3043.
34. Laver, W. G., Air, G. M., Webster, R. G. & Markoff, L. J. (1982). Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. Virology 122, 450-460.
35. Lentz, M. R., Air, G.M., Laver, W. G. & Webster, R.G. (1984). Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants. Virology 135, 257-265.
36. Lindstrom, S. E., Cox, N. J. & Klimov, A. (2004). Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology 328, 101-119.
37. Liu, C., Eichelberger, M. C., Compans, R. W. & Air, G. M. (1995). Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J Virol 69, 1099-1106.
38. Luther, P., Bergmann, K. C. & Oxford, J. S. (1984). An investigation of antigenic drift of neuraminidases of influenza A (H1N1) viruses. J Hyg (Lond) 92, 223-229.
39. Minin, V. N., Bloomquist, E. W. & Suchard, M. A. (2008). Smooth skyride through a rough skyline: Bayesian coalescent-based inference of population dynamics. Mol Biol Evol 25, 1459-1471.
40. Mitnaul, L. J., Matrosovich, M. N., Castrucci, M. R., Tuzikov, A. B., Bovin, N. V., Kobasa, D. & Kawaoka, Y. (2000). Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 74, 6015-6020.
41. Murphy, B. R., Kasel, J. A. & Chanock, R. M. (1972). Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286, 1329-1332.
42. Nagarajan, N. & Kingsford, C. (2011). GiRaF: robust, computational identification of influenza reassortments via graph mining. Nucleic Acids Res 39, e34.
43. Palese, P. & Compans, R. W. (1976). Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 33, 159-163.
44. Palese, P., Tobita, K., Ueda, M. & Compans, R. W. (1974). Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397-410.
45. Pereira, M. S. & Chakraverty, P. (1977). The laboratory surveillance of influenza epidemics in the United Kingdom 1968-1976. J Hyg (Lond) 79, 77-87.
46. Posada, D. (2008). jModelTest: phylogenetic model averaging. Mol Biol Evol 25, 1253-1256.
47. Pybus, O. G., Rambaut, A., Belshaw, R., Freckleton, R. P., Drummond, A. J. & Holmes, E. C. (2007). Phylogenetic evidence for deleterious mutation load in RNA viruses and its contribution to viral evolution. Mol Biol Evol 24, 845-852.
48. Rambaut, A., Pybus, O. G., Nelson, M. I., Viboud, C., Taubenberger, J. K. & Holmes, E. C. (2008). The genomic and epidemiological dynamics of human influenza A virus. Nature 453, 615-619.
49. Ronquist, F. & Huelsenbeck, J. P. (2003). MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572-1574.
50. Russell, C. A., Jones, T. C., Barr, I. G., Cox, N. J., Garten, R. J., Gregory, V., Gust, I. D., Hampson, A. W., Hay, A. J. & other authors (2008). Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26 (Suppl. 4), D31-D34.
51. Sandbulte, M. R., Westgeest, K. B., Gao, J., Xu, X., Klimov, A. I., Russell, C. A., Burke, D. F., Smith, D. J., Fouchier, R. A. & Eichelberger, M. C. (2011). Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A 108, 20748-20753.
52. Sauter, N. K., Bednarski, M. D., Wurzburg, B. A., Hanson, J. E., Whitesides, G. M., Skehel, J. J. & Wiley, D. C. (1989). Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. Biochemistry 28, 8388-8396.
53. Schild, G. C., Henry-Aymard, M., Pereira, M. S., Chakraverty, P., Dowdle, W., Coleman, M. & Chang, W. K. (1973). Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. Bull World Health Organ 48, 269-278.
54. Schild, G. C., Oxford, J. S., Dowdle, W. R., Coleman, M., Pereira, M. S. & Chakraverty, P. (1974). Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ 51, 1-11.
55. Schild, G. C., Newman, R. W., Webster, R. G., Major, D. & Hinshaw, V. S. (1980). Antigenic analysis of influenza A virus surface antigens: considerations for the nomenclature of influenza virus. Comp Immunol Microbiol Infect Dis 3, 5-18.
56. Scholtissek, C., Rohde, W., Von Hoyningen, V. & Rott, R. (1978). On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 87, 13-20.
57. Schulman, J. L. & Kilbourne, E. D. (1969). Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus. Proc Natl Acad Sci U S A 63, 326-333.
58. Schulman, J. L., Khakpour, M. & Kilbourne, E. D. (1968). Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2, 778-786.
59. Shapiro, B., Rambaut, A. & Drummond, A. J. (2006). Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol 23, 7-9.
60. Smith, D. J., Lapedes, A. S., de Jong, J. C., Bestebroer, T. M., Rimmelzwaan, G. F., Osterhaus, A. D. & Fouchier, R. A. (2004). Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376.
61. Smith, G. J., Vijaykrishna, D., Bahl, J., Lycett, S. J., Worobey, M., Pybus, O. G., Ma, S. K., Cheung, C. L., Raghwani, J. & other authors (2009). Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459, 1122-1125.
62. Stöhr, K. (2002). Influenza -WHO cares. Lancet Infect Dis 2, 517.
63. Swofford, D. L. (2003). PAUP*: Phylogenetic analysis using parsimony (and other methods), version 4. Sunderland, MA: Sinauer Associates.
64. Taubenberger, J. K. & Morens, D. M. (2006). 1918 Influenza: the mother of all pandemics. Emerg Infect Dis 12, 15-22.
65. Tong, S., Li, Y., Rivailler, P., Conrardy, C., Castillo, D. A., Chen, L. M., Recuenco, S., Ellison, J. A., Davis, C. T. & other authors (2012). A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109, 4269-4274.
66. Varghese, J. N., McKimm-Breschkin, J. L., Caldwell, J. B., Kortt, A. A. & Colman, P. M. (1992). The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327-332.
67. Wagner, R., Matrosovich, M. & Klenk, H. D. (2002). Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 12, 159-166.
68. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56, 152-179.
69. WHO (2003). Fact sheet Number 211. Influenza http://www.who.int/mediacentre/factsheets/fs211.
70. Wiley, D. C., Wilson, I. A. & Skehel, J. J. (1981). Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378.
71. Wilson, I. A. & Cox, N. J. (1990). Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8, 737-771.
72. Xu, X., Cox, N. J., Bender, C. A., Regnery, H. L. & Shaw, M. W. (1996). Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology 224, 175-183.
73. Yang, Z. (2007). PAML4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24, 1586-1591.
74. Zwickl, D. J. (2007). Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under themaximum likelihood criterion. PhD thesis, The University of Texas at Austin, TX, USA.